Search research articles
Contact Us
Filters
Showing results (361-370 of 481) with videos related to
Page
of 49
Sort By:
The Journal of Urology
|
August 21, 2007
Clinical safety of a viral vector based prostate cancer vaccine strategy
Philip M Arlen, Lisa Skarupa, Mary Pazdur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2004
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma
Susan E Bates, Susan Bakke, Min Kang, et al.
The Lancet. Oncology
|
January 24, 2018
Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study
Jung-Min Lee, Jayakumar Nair, Alexandra Zimmer, et al.
Annals of Surgical Oncology
|
September 25, 2009
Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy
R Taylor Ripley, Jeremy L Davis, Jacob A Klapper, et al.
BMC Gastroenterology
|
June 24, 2018
Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy
R Taylor Ripley, Deborah R Surman, Laurence P Diggs, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2003
Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children
Rohan Hazra, Frank M Balis, Antonella N Tullio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma
James L Gulley, Philip M Arlen, Kwong-Yok Tsang, et al.
British Journal of Haematology
|
September 9, 2004
Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation
Michael R Bishop, Seth M Steinberg, Ronald E Gress, et al.
The Lancet. Oncology
|
January 17, 2015
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
Anish Thomas, Arun Rajan, Arlene Berman, et al.
Bone Marrow Transplantation
|
February 2, 2021
Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease
Claire L Ruben, Filip Pirsl, Seth M Steinberg, et al.
Page
of 49
Search research articles
Search
Showing results (361-370 of 481) with videos related to
Sort By:
Page
of 49
The Journal of Urology
|
August 21, 2007
Clinical safety of a viral vector based prostate cancer vaccine strategy
Philip M Arlen, Lisa Skarupa, Mary Pazdur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2004
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma
Susan E Bates, Susan Bakke, Min Kang, et al.
The Lancet. Oncology
|
January 24, 2018
Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study
Jung-Min Lee, Jayakumar Nair, Alexandra Zimmer, et al.
Annals of Surgical Oncology
|
September 25, 2009
Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy
R Taylor Ripley, Jeremy L Davis, Jacob A Klapper, et al.
BMC Gastroenterology
|
June 24, 2018
Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy
R Taylor Ripley, Deborah R Surman, Laurence P Diggs, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2003
Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children
Rohan Hazra, Frank M Balis, Antonella N Tullio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma
James L Gulley, Philip M Arlen, Kwong-Yok Tsang, et al.
British Journal of Haematology
|
September 9, 2004
Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation
Michael R Bishop, Seth M Steinberg, Ronald E Gress, et al.
The Lancet. Oncology
|
January 17, 2015
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
Anish Thomas, Arun Rajan, Arlene Berman, et al.
Bone Marrow Transplantation
|
February 2, 2021
Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease
Claire L Ruben, Filip Pirsl, Seth M Steinberg, et al.
Page
of 49